Antioxidant therapy in intensive care

Current Opinion in Critical Care

Volumn 9, Issue 4, 2003, Pages 266-270

  Lovat, Robin ^a   Preiser, Jean Charles ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; ALPHA TOCOPHEROL; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CALCIUM CHANNEL BLOCKING AGENT; CEFTAZIDIME; COPPER; GLUTAMINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPERTENSIVE AGENT; INOTROPIC AGENT; MALONALDEHYDE; MANGANESE; MUSCLE RELAXANT AGENT; PROPOFOL; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; STEROID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRACE ELEMENT; UNINDEXED DRUG; VASOACTIVE AGENT; ZINC;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CRITICAL ILLNESS; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PRACTICE GUIDELINE; REVIEW; SEPSIS; SEPTIC SHOCK; VITAMIN INTAKE;

ANTIOXIDANTS; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE; OXIDATIVE STRESS;

EID: 0043269754     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200308000-00003     Document Type: Review

References (33)

1. Goodyear-Bruch C, Pierce JD: Oxidative stress in critically ill patients. Am J Crit Care 2002, 11:543-551. A nicely updated review of the mechanisms and clinical effects of oxidative injury, written to be easily understood by every intensive care professional.
2. Cuzzocrea S, Riley DP, Caputi AP, et al.: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001, 53:135-159. A very detailed review of the biochemical mechanisms of oxidative stress, followed by a comprehensive description of the antioxidant strategies.
3. Bulger EM, Maier RV: Antioxidants in critical illness. Arch Surg 2001, 136:1201-1207. A very clear and updated review of the pathogenesis of oxidative stress and of antioxidant defence mechanisms.
4. Brealey D, Brand M, Hargreaves I, et al.: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360(9328):219-223. A pioneering and very convincing demonstration of the presence of mitochondrial dysfunction in 28 patients with septic shock, in whom skeletal muscle ATP concentrations and the activity of mitochondrial complex I activity were inversely correlated with outcome.
5. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271 (5 Pt 1):C1424-C1437.
6. Grisham MB, Jourd'Heuil D, Wink DA: Nitric oxide: I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol 1999, 276(2 Pt 1):G315-G321.
7. Therond P, Bonnefont-Rousselot D, Davit-Spraul A, et al.: Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 2000, 3:373-384.
8. Motoyama T, Okamoto K, Kukita I, et al.: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003, 31:1048-1052. A large-scale (214 patients) longitudinal study of lipid peroxidation assessed by daily TBARS measurement. TBARS levels were correlated with the presence and the severity of MOF and with the duration of systemic inflammatory response syndrome.
9. Bela P, Bahl R, Sane AS, et al.: Oxidative stress status: possible guideline for clinical management of critically ill patients. Panminerva Med 2001, 43:27-31.
10. Alonso de Vega JM, Diaz J, Serrano E, et al.: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002, 30:1782-1786. A study performed on 68 patients, in which a correlation was found between the presence of SIRS and plasma concentrations of lipid peroxidation products and plasma total antioxidant capacity.
11. Frey B, Johnen W, Haupt R, et al.: Bioactive oxidized lipids in the plasma of cardiac surgical intensive care patients. Shock 2002, 18:14-17. A study demonstrating increased concentrations of lipid hydroperoxides in 68 patients undergoing cardiac surgery, regardless of the presence of postoperative MOF or SIRS.
12. Tsai K, Hsu T, Kong G, et al.: Is the endogenous peroxyl radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans? Free Radic Biol Med 2000, 28:926-933.
13. A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adults and pediatric patients. JPEN J Parenter Enteral Nutr 2002, 26:1SA-138S.
14. Mathy-Hartert M, Mouithys-Mickarad A, Kohnen S, et al.: Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000, 55:1066-1071.
15. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med 2002, 165::54-60. A nice in vitro demonstration of the antioxidant properties of propofol, which inhibited the oxidative hemolysis of erythrocyte membranes, synergistically with ascorbate.
16. Mouithys-Mickalad A, Mathy-Hartert M, Du G, et al.: Oxygen consumption and electron spin resonance studies of free radical production by alveolar cells exposed to anoxia: inhibiting effects of the antibiotic ceftazidime. Redox Rep. 2002, 7:85-94.
17. Kang MY, Tsuchiya M, Packer L, et al.: In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998, 42:4-12.
18. Wenisch G, Parschalk B, Weiss A, et al.; High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production. Clin Diagn Lab Immunol 1996, 3:423-428.
19. Higgins TL, Murray M, Kett DH, et al.: Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients. Intensive Care Med 2000, 26(Suppl 4):S413-S421.
20. Preiser JC, Van Gossum A, Berre J, et al.: Enteral feeding with a solution enriched with antioxidant vitamins A, C, and E enhances the resistance to oxidative stress. Crit Care Med 2000, 28:3828-3832.
21. Nelson JL, DeMichele SJ, Pacht ER, et al.: Enteral Nutrition in ARDS Study Group: effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. JPEN J Parenter Enteral Nutr 2003, 27:98-104.
22. Gadek JE, DeMichele SJ, Karlstad MD, et al.: Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420.
23. Nathens AB, Neff MJ, Jurkovich GJ, et al.: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002, 236:814-822. Very interesting large-scale randomized controlled trial confirming the beneficial effects of a prophylaxis with vitamin C and E in patients with trauma, in terms of both incidence of MOF and duration of mechanical ventilation.
24. Caparros T, Lopez J, Grau T; Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet: the effect on nosocomial infections and outcome. JPEN J Parenter Enteral Nutr 2001, 25:299-308.
25. Kiefer P, Vogt J, Radermacher P: From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine. Crit Care Med 2000, 28:3935-3936.
26. Heller AR, Groth G, Heller SC, et al.: N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001, 29:272-276. Clinical study on 30 patients randomized to high or low-dose N-acetylcysteine. Administration of the high dose was followed by an improvement in phagocytosis and a decrease in the activity of the oxidative burst of neutrophils.
27. Berger MM, Shenkin A: Trace elements in trauma and burns. Curr Opin Clin Nutr Metab Care 1998, 1:513-517.
28. Lassnigg A, Punz A, Barker R, et al.: Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 2003, 90:148-154.
29. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002, 16:1383-1388. Randomized controlled trial on 121 patients with moderate chronic renal failure, and scheduled for a coronary procedure with infusion of contrast medium. Post-procedure serum creatinine concentration decreased in the patients randomized to prophylactic N-acetylcysteine, and increased in the control group.
30. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000, 20:180-184.
31. Preiser JC, Wernerman J: Glutamine, a life-saving nutrient, but why? Crit Care Med 2003, (in press)
32. Flaring UB, Rooyackers OE, Wernerman J, et al.: Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond). 2003, 104:275-282. Controlled longitudinal study of the plasma and intramuscular concentrations of glutathione in surgical patients, which demonstrates that supplemental glutamine prevents the postoperative decrease in glutathione.
33. Boelens PG, Houdijk AP, de Thouars HN, et al.: Plasma taurine concentrations increase after enteral glutamine supplementation in trauma patients and stressed rats. Am J Clin Nutr 2003, 77:250-256. Consistent clinical and experimental findings of increased synthesis and uptake of taurine in 29 trauma patients, and in rats enterally fed with supplemental glutamine.